CCR1 antagonist J-113863 corrects the imbalance of pro- and anti-inflammatory cytokines in a SJL/J mouse model of relapsing-remitting multiple sclerosis-Reference-Cited by-同舟云学术

CCR1 antagonist J-113863 corrects the imbalance of pro- and anti-inflammatory cytokines in a SJL/J mouse model of relapsing-remitting multiple sclerosis

Published:2022-09 Issue:5 Volume:227 Page:152245
ISSN:0171-2985
Container-title:Immunobiology
language:en
Short-container-title:Immunobiology

Author:

Ansari Mushtaq A.,Nadeem Ahmed,Attia Sabry M.,Bakheet Saleh A.,Shahid Mudassar,Rehman Muneeb U.,Alanazi Mohammed M.,Alhamed Abdullah S.,Ibrahim Khalid E,Albekairi Norah A,Ahmad Sheikh F.

Funder

King Saud University

Publisher

Elsevier BV

Subject

Hematology,Immunology,Immunology and Allergy

Reference102 articles.

1. Mitochondrial damage and histotoxic hypoxia: a pathway of tissue injury in inflammatory brain disease?;Aboul-Enein;Acta Neuropathol.,2005

2. Dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in children with autism;Ahmad;Mol Neurobiol.,2017

3. The potent immunomodulatory compound VGX-1027 regulates inflammatory mediators in CD4+ T cells, which are concomitant with the prevention of neuroimmune dysregulation in BTBR T+ Itpr3tf/J mice;Ahmad;Life Sci.,2019

4. 5-aminoisoquinolinone attenuates social behavior deficits and immune abnormalities in the BTBR T+ Itpr3tf/J mouse model for autism;Ahmad;Pharmacol Biochem Behav.,2020

5. CCR1 antagonist ameliorates experimental autoimmune encephalomyelitis by inhibition of Th9/Th22-related markers in the brain and periphery;Al-Mazroua;Mol Immunol.,2022

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammatory Role of CCR1 in the Central Nervous System;Neuroimmunomodulation;2024-08-08

2. Administration of ROS-Scavenging Cerium Oxide Nanoparticles Simply Mixed with Autoantigenic Peptides Induce Antigen-Specific Immune Tolerance against Autoimmune Encephalomyelitis;ACS Applied Materials & Interfaces;2024-06-21

3. Synergistic antitumor activity by dual blockade of CCR1 and CXCR2 expressed on myeloid cells within the tumor microenvironment;British Journal of Cancer;2024-05-15

4. A novel combination approach to effectively reduce inflammation and neurodegeneration in multiple sclerosis models;Neurochemistry International;2024-05

5. Exploring the immune‐modulating properties of boswellic acid in experimental autoimmune encephalomyelitis;APMIS;2024-04-02